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Background: Kimura's disease (KD) is a slowly progressing rare, benign inflammatory disorder of the soft tissues. It
typically presents as subcutaneous tumor-like nodules, located most frequently in the head and neck region. KD is
often accompanied by increased peripheral eosinophilia and elevated levels of serum immunoglobulin (Ig) E. There
is renal involvement in approximately 12-16% of KD cases. We report the case of a 23-year-old Chinese man who
was found to have KD associated with nephrotic syndrome.
Case presentation: A 23-year-old Chinese man presented with edema in both legs and a mass in ulnar side of
his right upper arm on August 8th 2013. Before admission to our hospital, an ultrasound examination revealed
swollen lymph nodes in the medial aspect of his right upper arm, proximal to the elbow. The patient was admitted on
August 19th 2013 as a result of edema, severe proteinuria, and low serum albumin levels. He had a white blood cell
count of 7.7 × 109 cells/L, 48.5% eosinophils, 4+ albuminuria, 24-hour urinary protein excretion 9.3 g, serum protein
50.3 g/L; serum albumin 16 g/L and IgE 1,510 IU/ml. A biopsy of the epitrochlear nodes revealed eosinophilic
hyperplastic lymphogranulomatous tissue. A renal biopsy indicated focal segmental glomerulosclerosis (FSGS)
(cellular variant) with no infiltration of eosinophil in renal interstitium. The results of immune-staining on the renal
biopsy were negative for IgG, IgA, IgM, C3 and C1q. The electron microscopic analysis showed podocyte effacement.
His final diagnosis was Kimura's disease associated with nephrotic syndrome. He received methylprednisolone therapy
as well as symptomatic treatment, and was discharged with key indicators in normal range on September 17th 2013.
During the year following, he had methylprednisolone at a maintenance dose of 8 mg/day, and no relapses occurred
up to now.
Conclusion: Methylprednisolone therapy is effective in KD associated with nephrotic syndrome, and long-term
administration of methylprednisolone at maintenance dose may be a way to prevent relapses of KD.
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Kimura’s disease (KD) is a rare, chronic inflammatory
disorder that affects the lymph nodes, soft tissues, and
salivary glands. It occurs predominantly in Asian males
with a male to female ratio of approximately 9.1:3.5 [1].
There are about 300 reported cases globally, with
most occurring in Asia [2]. The etiology of KD has yet
to be resolved.
The characteristic manifestations of KD include sub-
cutaneous tumor-like masses in the head and neck re-
gion, as well as subcutaneous nodules with eosinophilic
lymphoid granulomas. Multiple organs can be affected,
with about 12-16% of patients suffering renal involve-
ment [3]. Indeed, when there is renal involvement, the
disease may present initially as a nephrotic syndrome.
KD is diagnosed after the exclusion of malignancies (e.g.,
T-cell lymphoma and Hodgkin’s disease [1,3]) based on
the presence of a painless subcutaneous tumor-like mass,
increased immunoglobulin (Ig)E levels, eosinophilia and a
biopsy that shows the abnormal proliferation of lymphoid
follicles and vascular endothelium.
Here, we present the case of a patient with KD associ-
ated with nephrotic syndrome characterized by focal
segmental glomerulosclerosis (FSGS). We also provide an
analysis of the diagnostic strategy for recognizing KD
associated with nephrotic syndrome, as well as treatments
and methods to prevent the relapse of this condition.Case presentation
A 23-year-old Chinese man presented with edema in
both legs and a mass in ulnar side of his right upper arm
on August 8th 2013. The patient reported that the edema
had been present for 11 days and that the mass had been
palpable for 3 years, and was first detected in October
2010. According to the patient’s recollection, it had appar-
ently increased in size since June 2013 with accompanyingA
Figure 1 Lymph node and renal findings. A: MRI of right arm: a soft tissu
right upper arm, along the brachial artery; B: Part of the glomerulus is more h
found in renal interstitium.warmth of the overlying skin. The patient had not
received any prior treatment for these conditions.
Before admission to our hospital, the patient devel-
oped worsened lower limb edema, abdominal distention,
and oliguria. Two days later, an ultrasound examination
revealed swollen lymph nodes in the medial aspect of
his right upper arm, proximal to the elbow. Because the
appearance of the swollen nodes was consistent with in-
flammation, the patient was prescribed cefprozil, which
resulted in a reduction in the swelling.
The patient was admitted on August 19th 2013 as a
result of edema, severe proteinuria, and low serum
albumin levels. Tender epitrochlear nodes that were
poorly mobile were palpable in his right upper arm,
with the largest being approximately 30 × 20 mm in size
in physical examination. Hematology revealed a white
blood cell count of 7.7 × 109 cells/L, 48.5% eosinophils,
and a platelet count of 172 × 109 platelets/L. Urinalysis
revealed 4+ albuminuria and 2+ red blood cells per
high power field. His 24-hour urinary protein excretion
was 9,3g. A blood panel yielded the following results:
total serum protein, 50.3 g/L; serum albumin, 16 g/L;
serum cholesterol; 13.36 mmol/L; serum triglycerides,
1.85 mmol/L; high-density lipoprotein, 2.32 mmol/L;
and low-density lipoprotein level, 9.37 mmol/L. In im-
munological tests, IgE level was as high as 1,510 IU/ml
(reference value 0-100 IU/ml), with normal C3, C4,
IgG, IgA, and IgM (1.54g/L, 0.37g/L, 5.82g/L, 3.69g/L
and 1.44g/L respectively).
On magnetic resonance imaging (MRI) examination, a
soft tissue-density mass was observed within the right
medial upper arm, distributed along the brachial artery
(Figure 1A). A biopsy of the epitrochlear nodes revealed
eosinophilic hyperplastic lymphogranulomatous tissue.
A renal biopsy indicated focal segmental glomerulo-
sclerosis (FSGS) (cellular variant) with no infiltration of
eosinophil in renal interstitium (Figure 1B). The resultsB
e density with a vague boundary (arrows) within the medial aspect of the
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for immunoglobulin G (IgG), IgA, IgM, C3 and C1q.
The electron microscopic analysis showed podocyte ef-
facement. Analysis of a bone marrow sample obtained
by aspiration indicated an abnormally high proportion of
eosinophils (total eosinophils 14%, metamyelocyte eosin-
ophils, 2%; rod nuclear eosinophils, 2%; and leaf nuclear
eosinophils, 10%). A bone marrow biopsy showed a pre-
dominance of eosinophils among the granulocytes. The
patient had a normal karyotype, and mutation screening
from a peripheral blood sample revealed no gene fusions
of FIP1L1-PDGFRα and ETV6-PDGFRβ. No abnormal-
ities were identified at 8p12/8p11.1-q11.1 using fluores-
cence in situ hybridization and the V617F single
nucleotide polymorphism of JAK2.
The final diagnosis for this patient was KD associated
with nephrotic syndrome (FSGS, cellular variant). He
was given intravenous methylprednisolone (80 mg/day)
for 3 days beginning on August 29th, 2013, followed by
oral methylprednisolone (36 mg/d, once a day). Mean-
while, he received famotidine (20 mg, twice a day),
rocaltrol (0.25 μg, once a day), and caltrate D (300 mg,
twice a day) for symptomatic treatment. Six days after
the initiation of glucocorticoid treatment, the edema had
largely resolved, his serum albumin levels had improved,
and his urine was negative for proteinuria. Additionally,
the tumor-like mass reduced in size, and his eosinophil
ratio and eosinophil counts normalized. Two weeks later,
the serum albumin levels had increased to within the
normal range and only one soft, smooth, mobile lymph
node (5 × 5 mm cross-sectional area) was palpable in his
right arm. Therefore, the patient was discharged on
September 17th 2013. After a 2-month period of methyl-
prednisolone at a dose of 36 mg/day, the prescribed
methylprednisolone dose was tapered by 4 mg every 2
weeks until a maintenance dose of 8 mg/day was
reached. During the year following discharge, serum al-
bumin levels and urinalysis test results remained normal
and no relapses occurred.
Discussion
In this report, we described the case of a 23-year-old
Chinese man who developed KD with nephrotic syn-
drome 3 years after the appearance of a tumor-like sub-
cutaneous mass. The subcutaneous mass was located in
the right arm, which is atypical for KD.
There is no consensus regarding the optimal treatment
for KD. Treatment options include surgical excision, corti-
costeroids, chemotherapeutic agents, and radiotherapy [4].
Although KD is benign, it is prone to recurrence [5] and
can be disfiguring. Corticosteroids are particularly applic-
able for cases of KD with renal involvement. In the present
case, we observed a good response to 3 days of intravenous
methylprednisolone (80 mg/day) with subsequent oralmethylprednisolone (36 mg/day), and therefore pro-
ceeded to taper the methylprednisolone dosage to a
long-term maintenance dose (8 mg/day). At the time of
writing this report, this regimen appears to have
prevented a relapse of KD.
The pathological mechanism of renal involvement in KD
is not yet known. Various renal pathologies may present in
KD associated with nephrotic syndrome, including min-
imal change disease [6], mesangio-proliferative glomerulo-
nephritis [7], membranous nephropathy [8], FSGS, IgA
nephropathy, IgM nephropathy, and IgE nephropathy.
Inexplicably, we observed the complete remission of the
nephrotic syndrome in this patient within 6 days of
commencing corticosteroid treatment. This is remarkably
rapid given that the average remission time for FSGS in
primary nephrotic syndrome patients treated with cortico-
steroids is 4 months.
Rare diseases are likely to be misdiagnosed as doctors
lack the required clinical experience. This can often result
in a long interval between the onset of symptoms and the
correct diagnosis [9], which prevents the initiation of
prompt treatment. In this patient, 3 years elapsed before
he was diagnosed correctly. To reduce diagnostic errors,
enhancing the awareness of rare diseases is necessary for
doctors, in addition to having wide-ranging relevant
knowledge and critical thinking abilities.
Conclusions
We describe a successful treatment of Kimura's disease
associated with nephrotic syndrome in a patient with
methylprednisolone, and prevention of Kimura's disease
relapses with long-term administration of methylpred-
nisolone at maintenance dose. Although we cannot
conclude long-term administration of methylpredniso-
lone is useful as an effective strategy to prevent relapses
yet, our report suggests that further studies are required.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor of this journal.
Abbreviations
FSGS: Focal segmental glomerulosclerosis; Ig: Immunoglobulin; KD: Kimura's
disease; MRI: Magnetic resonance imaging.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SLZ, PFW, and ZFZ designed and drafted the manuscripts. SLZ participated
in the interpretation of patient’s data and in the revision of the final draft.
SLZ, JHC, QNX, and LY were closely involved in patients care. All authors
have read and approved the final manuscript.
Acknowledgements
The authors express their gratitude to the patient in this report.
Zhu et al. BMC Nephrology  (2015) 16:10 Page 4 of 4Author details
1Department of Nephrology, Nanshan Hospital, Shenzhen University, 89
Taoyuan Road, Shenzhen 518052, P. R. China. 2Health Science Center,
Shenzhen University, Shenzhen, China.
Received: 7 November 2014 Accepted: 27 January 2015
References
1. Wang DY, Mao JH, Zhang Y, Gu WZ, Zhao SA, Chen YF, et al. Kimura
disease: a case report and review of the Chinese literature. Nephron Clin
Pract. 2009;111:c55–61.
2. Reed RJ, Terazakis N. Subcutaneous angioblastic lymphoid hyperplasia with
eosinophilia (Kimura's disease). Cancer. 1972;29:489–97.
3. Rajpoot DK, Pahl M, Clark J. Nephrotic syndrome associated with Kimura
disease. Pediatr Nephrol. 2000;14:486–8.
4. Jun R, Liu XK, Zeng K. Successful treatment of angiolymphoid hyperplasia
with eosinophilia and Kimura's disease in the same patient with surgery.
Dermatol Ther. 2014;27:36–8.
5. Othman SK, Daud KM, Othman NH. Kimura's disease: a rare cause of
nephrotic syndrome with lymphadenopathy. MJMS. 2011;18:88–90.
6. Matsumoto K, Katayama H, Hatano M. Minimal-change nephrotic syndrome
associated with subcutaneous eosinophilic lymphoid granuloma (Kimura's
disease). Nephron. 1988;49:251–4.
7. Qunibi WY, Al-Sibai MB, Akhtar M. Mesangio-proliferative glomerulonephritis
associated with Kimura's disease. Clin Nephrol. 1988;30:111–4.
8. Yamada A, Mitsuhashi K, Miyakawa Y, Kosaka K, Takehara K, Iijima M, et al.
Membranous glomerulonephritis associated with eosinophilic
lymphfolliculosis of the skin (Kimura's disease): report of a case and review
of the literature. Clin Nephrol. 1982;18:211–5.
9. Heemstra HE. From Research on Rare Disease to new Orphan Drug
Development. The Netherlands, Utrecht: Utrecht University, Division of
Pharmacoepidemiology and Pharmacotherapy; 2009.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
